About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Multiple System Atrophy Multidisciplinary Clinic | Clinical Trials | Clareo Health

Back to clinical trial search

RECRUITINGNCT03811808

Multiple System Atrophy Multidisciplinary Clinic

This is a prospective cohort study to examine the disease burden of multiple system atrophy and the impact of multidisciplinary care on quality of life and caregiver burden. Data will be collected thr...

Lead sponsor: University of Texas Southwestern Medical Center•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Amy Conger

CONTACT

214-648-0214 [email protected]

Steve Hopkins, CCRC

CONTACT

214-648-9275 [email protected]

Sponsors

Lead Sponsor

University of Texas Southwestern Medical Center

Study Procedures: Participants and caregivers will attend a multidisciplinary MSA clinic one day every four months. In addition to the standard of care, they will be asked to complete both online and paper questionnaires, including the following: * UMSARS (Unified MSA Rating Scale) * MSA QOL * CES-D * OHQ * Compass-31 * BIC * UPDRS * SARA * MDS Scale * CGI * MoCA Participants will be part of the study as long as they are a patient of the MSA clinic, and will be contacted for follow-up information up to five years.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Subject must be a patient in the UT Southwestern MSA clinic and be able to attend the multidisciplinary clinic every 4 months
•Patients with possible or probable MSA based on established criteria
•Subjects must be 18 years or older

Exclusion Criteria

•Patients that are unable to give consent
•Minor patients (younger than age 18)
•Non-English speaking patients
•Subjects that are diagnosed with dementia

Related studies

Active Not RecruitingPhase 2

A Phase 2 Study of ONO-2808 in Patients With Multiple System Atrophy

NCT05923866 · Multiple System Atrophy (MSA)

COMPLETEDEARLY Phase 1

Effect of Verdiperstat on Microglial Activation in Well-characterized MSA Patients

NCT04616456 · Multiple System Atrophy, Multiple System Atrophy, Cerebellar Variant, and more

PROgressive Supranuclear Palsy CorTico-Basal Syndrome Multiple System Atrophy Longitudinal Study UK

NCT02778607 · Progressive Supranuclear Palsy (PSP), Corticobasal Degeneration, and more

Oligomeric Alpha-synuclein in Multiple System Atrophy

NCT01485549 · Multiple System Atrophy (MSA)

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 1, 2025Terms

Trial snapshot

StatusRECRUITING

Phase—

Enrollment200

Start dateMar 2016

Last updatedMay 1, 2025

Condition

Multiple System Atrophy (MSA)

Locations shown

UT Southwestern Medical Center

Dallas, Texas

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 1, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions